275 related articles for article (PubMed ID: 10381783)
21. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
22. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive.
Ossipov MH; Lopez Y; Nichols ML; Bian D; Porreca F
Neurosci Lett; 1995 Oct; 199(2):87-90. PubMed ID: 8584250
[TBL] [Abstract][Full Text] [Related]
23. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
24. Peripheral morphine analgesia: synergy with central sites and a target of morphine tolerance.
Kolesnikov YA; Jain S; Wilson R; Pasternak GW
J Pharmacol Exp Ther; 1996 Nov; 279(2):502-6. PubMed ID: 8930151
[TBL] [Abstract][Full Text] [Related]
25. Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice.
Bryant CD; Roberts KW; Byun JS; Fanselow MS; Evans CJ
Pharmacol Biochem Behav; 2006 Dec; 85(4):769-79. PubMed ID: 17196637
[TBL] [Abstract][Full Text] [Related]
26. Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat.
Dunbar S; Yaksh TL
Anesthesiology; 1996 May; 84(5):1177-88. PubMed ID: 8624012
[TBL] [Abstract][Full Text] [Related]
27. Analgesic synergy between topical morphine and butamben in mice.
Kolesnikov YA; Cristea M; Pasternak GW
Anesth Analg; 2003 Oct; 97(4):1103-1107. PubMed ID: 14500165
[TBL] [Abstract][Full Text] [Related]
28. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice.
DeLander GE; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1992 Dec; 263(3):1097-104. PubMed ID: 1335055
[TBL] [Abstract][Full Text] [Related]
29. Effects of systemic, intracerebral, or intrathecal administration of an N-methyl-D-aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats.
McNally GP; Westbrook RF
Behav Neurosci; 1998 Aug; 112(4):966-78. PubMed ID: 9733203
[TBL] [Abstract][Full Text] [Related]
30. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
Lutfy K; Doan P; Weber E
Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
[TBL] [Abstract][Full Text] [Related]
31. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin.
Kosson D; Klinowiecka A; Kosson P; Bonney I; Carr DB; Mayzner-Zawadzka E; Lipkowski AW
Eur J Pain; 2008 Jul; 12(5):611-6. PubMed ID: 18068383
[TBL] [Abstract][Full Text] [Related]
32. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
33. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.
Popik P; Kozela E; Danysz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858
[TBL] [Abstract][Full Text] [Related]
34. Effects of N-methyl-D-aspartate receptor antagonists on the analgesia and tolerance to D-Ala2, Glu4 deltorphin II, a delta 2-opioid receptor agonist in mice.
Bhargava HN; Zhao GM
Brain Res; 1996 May; 719(1-2):56-61. PubMed ID: 8782863
[TBL] [Abstract][Full Text] [Related]
35. Interactions of the potent D-amino acid oxidase inhibitor CBIO with morphine in pain and tolerance to analgesia.
Gong N; Wang YC; Wang HL; Ma AN; Hashimoto K; Wang YX
Neuropharmacology; 2012 Sep; 63(3):460-8. PubMed ID: 22587944
[TBL] [Abstract][Full Text] [Related]
36. Analgesic synergy between topical opioids and topical non-steroidal anti-inflammatory drugs in the mouse model of thermal pain.
Kolesnikov Y; Sõritsa D
Eur J Pharmacol; 2008 Jan; 579(1-3):126-33. PubMed ID: 18001710
[TBL] [Abstract][Full Text] [Related]
37. Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
Rady JJ; Holmes BB; Tseng LF; Fujimoto JM
J Pharmacol Exp Ther; 2001 May; 297(2):582-9. PubMed ID: 11303046
[TBL] [Abstract][Full Text] [Related]
38. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
[TBL] [Abstract][Full Text] [Related]
39. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats.
Bespalov A; Kudryashova M; Zvartau E
Eur J Pharmacol; 1998 Jun; 351(3):299-305. PubMed ID: 9721021
[TBL] [Abstract][Full Text] [Related]
40. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C.
Mao J; Price DD; Mayer DJ
J Neurosci; 1994 Apr; 14(4):2301-12. PubMed ID: 7908958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
